Search Results
Dec 10, 2025, 12:00 ET SkinSight™ AI by ModuleMD: Smarter Skin Analysis, Faster Clinical Decisions
move beyond subjective measurement and towards measurable, outcomes-based allergy care.Supporting Practices Amid CPT 95004 PressureWith reimbursement for CPT 95004 remaining flat, allergy practices must find ways to optimize accuracy and efficiency without increasing labour. SkinSight™
More news about: ModuleMD Healthcare Solutions Private Limited
Dec 08, 2025, 16:01 ET Shareholders who lost money in shares of Inspire Medical Systems, Inc. (NYSE: INSP) Should Contact Wolf Haldenstein Immediately
onboarding steps before purchasing or implanting the device.Billing and Medicare Reimbursement Issues:Although Inspire V's CPT code was approved for Medicare, billing software updates did not take effect until July 1, delaying claims and reimbursement processing.→
More news about: Wolf Haldenstein Adler Freeman & Herz LLP
Dec 08, 2025, 09:33 ET Tennessee's Newest Health and Wellness Sanctuary, Level, Celebrates the Holidays with Grand Opening on December 13th
30 years of experience in healthcare. Specializes in sports medicine, performance optimization, and recovery science.Stephanie Hewitt (NASM-CPT, NC), Director of Operations – Brings extensive operational expertise in scaling wellness, medical, and lifestyle brands.Joey Flamm
More news about: Level
Dec 05, 2025, 11:13 ET Sprocket Security Earns Repeat Recognition in G2's Winter 2025 Relationship Index for Penetration Testing
and deepen partnerships with customers. This repeat achievement underscores the dependability and consistency of our continuous penetration testing (CPT) model, which has rapidly become a trusted foundation for security teams seeking real-time, ongoing assurance. "Earning these awards again is
More news about: Sprocket Security
Dec 05, 2025, 11:06 ET SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
onboarding needed to begin using the product. Inspire also disclosed billing and reimbursement challenges, explaining that although Medicare had approved a CPT code for Inspire V, the necessary software updates for claims processing did not go into effect until July 1. As a result, implanting centers could not
More news about: Faruqi & Faruqi, LLP
Dec 02, 2025, 09:00 ET CMS Finalizes OPPS Payment for Eko Health's SENSORA® Platform, Expanding Reimbursement for AI-Enabled Cardiac Disease Detection in Hospital-Associated Outpatient Care
identification of heart disease within standard outpatient workflows. This follows CMS's July 2025 proposed rule, which first assigned SENSORA's Category III CPT code (0962T) to APC 5734. The inclusion in the final rule reflects growing institutional support for AI tools that strengthen front-line cardiac evaluation."This
More news about: Eko Health
Dec 01, 2025, 14:35 ET INSP INVESTOR ALERT: Inspire Medical (INSP) Sued Over Claims It Misled Investors on Next-Generation Device Launch -- Hagens Berman
failed to complete the necessary training, contracting, and onboarding criteria prior to purchasing and implanting Inspire V. Crucially, despite the CPT code for Medicare patients being approved, the necessary software updates for claims submissions and processing did not take effect until July 1 of 2025.
More news about: Hagens Berman Sobol Shapiro LLP
Nov 30, 2025, 09:45 ET INSP DEADLINE: Faruqi & Faruqi Reminds Inspire Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 - INSP
onboarding needed to begin using the product. Inspire also disclosed billing and reimbursement challenges, explaining that although Medicare had approved a CPT code for Inspire V, the necessary software updates for claims processing did not go into effect until July 1. As a result, implanting centers could not
More news about: Faruqi & Faruqi, LLP
Nov 28, 2025, 17:35 ET Inspire Medical (INSP) Faces Securities Class Action Over Claims It Misled Investors on Next-Generation Device Launch -- Hagens Berman
failed to complete the necessary training, contracting, and onboarding criteria prior to purchasing and implanting Inspire V. Crucially, despite the CPT code for Medicare patients being approved, the necessary software updates for claims submissions and processing did not take effect until July 1 of 2025.
More news about: Hagens Berman Sobol Shapiro LLP
Nov 26, 2025, 08:50 ET Inspire Medical (INSP) Faces Securities Class Action Over Claims It Misled Investors on Next-Generation Device Launch -- Hagens Berman
failed to complete the necessary training, contracting, and onboarding criteria prior to purchasing and implanting Inspire V. Crucially, despite the CPT code for Medicare patients being approved, the necessary software updates for claims submissions and processing did not take effect until July 1 of 2025.
More news about: Hagens Berman Sobol Shapiro LLP
Nov 25, 2025, 16:20 ET Inspire Medical (INSP) Sued Over Claims It Misled Investors on Next-Generation Device Launch -- Hagens Berman
failed to complete the necessary training, contracting, and onboarding criteria prior to purchasing and implanting Inspire V. Crucially, despite the CPT code for Medicare patients being approved, the necessary software updates for claims submissions and processing did not take effect until July 1 of 2025.
More news about: Hagens Berman Sobol Shapiro LLP
Nov 25, 2025, 07:30 ET Medicare Finalizes Reimbursement for Caristo's CaRi-Plaque™ Across Hospital and Office Settings
The decision completes the two major Medicare reimbursement pathways for nationwide use of CaRi-Plaque. Based on a new Category I CPT® code (75577) for AI quantification and characterization of coronary atherosclerotic plaque derived from analysis of CCTA, CMS recently set a 2026 Physician
More news about: CARISTO DIAGNOSTICS
Nov 24, 2025, 08:00 ET Sera Announces Publication Acceptance for PRIME Study
market growth; potential third-party payer coverage and reimbursement; new reimbursement methodologies applicable to the PreTRM Test, including new CPT codes and payment rates for those codes; changes in FDA regulation of laboratory-developed tests; the intellectual property rights protecting our tests
More news about: Sera Prognostics, Inc.
Nov 21, 2025, 10:05 ET UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
onboarding needed to begin using the product. Inspire also disclosed billing and reimbursement challenges, explaining that although Medicare had approved a CPT code for Inspire V, the necessary software updates for claims processing did not go into effect until July 1. As a result, implanting centers could not
More news about: Faruqi & Faruqi, LLP
Nov 19, 2025, 08:54 ET IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 2025
early-stage breast cancer, post-market activity, and recommendations from professional medical associations. ProSense® currently has reimbursement under the CPT III code which covers $3,800 of facility costs, which is expected to increase to slightly over $4,000 effective January 2026.
More news about: IceCure Medical
Nov 19, 2025, 08:46 ET CMS Establishes National Pricing for Vesiflo's inFlow™ Voiding Prosthesis
inFlow™ Voiding Prosthesis, following the Centers for Medicare & Medicaid Services (CMS) decision to establish national pricing for the CPT® codes related to physician procedures for the device. This decision, included in the Calendar Year 2026 Medicare Physician Fee Schedule (PFS) Final
More news about: Vesiflo
Nov 18, 2025, 11:03 ET Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman
onboarding criteria required prior to the purchase and implant of Inspire V." The company also said that, although Inspire V's CPT code was approved for Medicare patients, "software updates for claims submissions and processing did not take effect until July 1." This meant that
More news about: Hagens Berman Sobol Shapiro LLP
Nov 14, 2025, 12:30 ET Intrinsic Therapeutics Announces the First Endoscopic Barricaid Implantation in the Great Lakes Region by Dr. Nick Nenadovich
multicenter, Level I RCT demonstrating superior outcomes to discectomy alone was published in JAMA with five-year follow-up results. A new Category I CPT Code 63032 for bone-anchored annular closure will go into effect on January 1, 2026. *Some studies are outside FDA indications.
More news about: Intrinsic Therapeutics, Inc.
Nov 14, 2025, 10:26 ET INSP DEADLINE: Faruqi & Faruqi Reminds Inspire Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 - INSP
onboarding needed to begin using the product. Inspire also disclosed billing and reimbursement challenges, explaining that although Medicare had approved a CPT code for Inspire V, the necessary software updates for claims processing did not go into effect until July 1. As a result, implanting centers could not
More news about: Faruqi & Faruqi, LLP
Nov 13, 2025, 16:05 ET SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
market growth; potential third-party payer coverage and reimbursement; new reimbursement methodologies applicable to the PreTRM Test, including new CPT codes and payment rates for those codes; changes in FDA regulation of laboratory-developed tests; the intellectual property rights protecting our tests
More news about: Sera Prognostics, Inc.
Nov 13, 2025, 10:37 ET BOOST TREADMILLS LAUNCHES BOOST 3: REVOLUTIONARY MICROGRAVITY TREADMILL MAKES ELITE PERFORMANCE AND RECOVERY ACCESSIBLE TO HOMES AND CLINICS
bracket). Insurance Support: The company provides assistance with Letters of Medical Necessity and CPT coding guidance for clinics. Many insurance plans may cover 40-60% of costs for individuals when prescribed by a physician for qualifying conditions.
More news about: Boost Treadmills
Nov 13, 2025, 08:25 ET Shareholders who lost money in shares of Inspire Medical Systems, Inc. (NYSE: INSP) Should Contact Wolf Haldenstein Immediately
device. Billing and Medicare Reimbursement Issues: Although Inspire V's CPT code was approved for Medicare, billing software updates did not take effect until July 1, delaying claims and reimbursement processing.→
More news about: Wolf Haldenstein Adler Freeman & Herz LLP
Nov 11, 2025, 10:13 ET Olympus Corporation Announces Newest Appointments to Help Drive Innovation and Patient Safety for Respiratory Business
in his work with the American Thoracic Society/American College of Chest Physicians Clinical Practice Committee on writing and valuing bronchoscopy CPT codes, including those for endobronchial ultrasound (EBUS) and navigational bronchoscopy. Along with transforming the Cleveland
More news about: Olympus Corporation of the Americas
Nov 10, 2025, 13:32 ET Robbins Geller Rudman & Dowd LLP Announces that Inspire Medical Systems, Inc. (INSP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
implant of [Inspire V]," the complaint alleges. Defendants further admitted that, although Inspire V's CPT code had been approved for Medicare patients, "software updates for claims submissions and processing did not take effect until July 1," which meant
More news about: Robbins Geller Rudman & Dowd LLP
Nov 10, 2025, 09:00 ET Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman
onboarding criteria required prior to the purchase and implant of Inspire V." The company also said that, although Inspire V's CPT code was approved for Medicare patients, "software updates for claims submissions and processing did not take effect until July 1." This meant that
More news about: Hagens Berman Sobol Shapiro LLP